Jiangsu Hengrui Medicine Co. Ltd

Headquarters: Lianyungang, China

Employees: 28,903

show_chart SSE: 600276 -0.02%

Market Cap

CN¥246.80 Billion

CNY as of Jan. 1, 2023

US$35.78 Billion

history Market Cap History

Jiangsu Hengrui Medicine Co. Ltd market capitalization over time

Evolution of Jiangsu Hengrui Medicine Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Jiangsu Hengrui Medicine Co. Ltd

Detailed Description

Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications. The company was founded in 1970 and is based in Lianyungang, China.

Stocks & Indices

Jiangsu Hengrui Medicine Co. Ltd has the following listings and related stock indices.

Stock: SSE: 600276



38 Huanghe Rd Eco & Tech Dev Park

Lianyungang, 222000


Phone: 86 518 8122 0983